Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

European Research Council grant · Running

DeCodeGels De-Coding Adhesion, Degradation and Immunomodulation Properties of Self-Assembling Peptide Hydrogels for Programmed Tendon Regeneration

Coordinator
Syddansk Universitet, Denmark
Runs
1 September 2026 to 31 August 2031
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
2 organisations in 2 countries
Type
European Research Council grant
Grant agreement
101219936

What the project is doing

In the project's own words, from its summary on CORDIS.

Despite recent advances there is still a clear need for injectable and regenerative biomaterials that can spatiotemporally modulate the inflammation and, in parallel, induce the desired regenerative pathways. Usually, biopolymeric hydrogels need a narrow and somewhat opposite set of physical and biological properties which allow for their degradation, adhesion as well as immune cell invasion to allow complete tissue regeneration.

To resolve this issue, following my unique interdisciplinary expertise, I plan to develop new injectable self-assembling peptides (SAPs) biomaterials that simultaneously: i) possess improved adhesion to local tissues in vivo, ii) exhibit controlled degradation matching the desired regeneration outcome, and iii) allow tissue regeneration by enabling controlled immune cells invasion and progression of inflammation from neighbouring tissues.

The basic rules for decoupling these properties will have broad implications to the biomedical community. Following injury, inflammation is the trigger of tissue repair, however, chronic inflammation is detrimental. The persistent inflammatory nature of tendinopathy contributes to localized tissue damage, often developing to a low-grade chronic inflammation with recurring tears. Unlike conventional anti-inflammatory therapies that merely address symptoms, DeCodeGels introduces an innovative therapeutic strategy utilizing temporally modulating SAPs biomaterials.

This groundbreaking approach aims to i) initially induce a controlled, localized pro-inflammatory state, then ii) gradually transition this state to an anti-inflammatory environment over time to ultimately achieve a dual-purpose therapy that reverses chronic inflammation and promotes therapeutically driven healthy tissue regeneration. This single, multifaceted treatment has the potential to revolutionize our approach to chronic inflammatory conditions, offering a path to true healing rather than just symptomatic relief.

Topics

Who is involved

OrganisationCityCountryRole
Syddansk UniversitetOdense MDenmarkCoordinator
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI